Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xingjiang,Hu

第一单位： Research Center of Clinical Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

作者： Xingjiang,Hu ^[1] ; Hui,Yu ^[2] ; Yunliang,Zheng ^[3] ; Qiao,Zhang ^[4] ; Meihua,Lin ^[1] ; Jialei,Wang ^[2] ; Yunqing,Qiu ^[1]

作者单位： Research Center of Clinical Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. ^[1] Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. ^[2] Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. ^[3] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. ^[4]

关键词 brain metastasis immune checkpoint inhibitor meta-analysis prognosis survival

DOI 10.3389/fonc.2020.564382

PMID 33194639

发布时间 2020-11-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2020年10卷

564382页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除